INTRODUCTION
The liver plays a central role in metabolic regulation, particularly when considering glucose and lipid metabolism. With respect to glucose, the liver stores glucose as glycogen after meals and produces glucose in the postabsorptive state and during starvation through first glycogenolysis and then gluconeogenesis. In lipid metabolism, the liver oxidizes fatty acids completely to C0 2 or partially to ketone bodies. It is also capable of lipogenesis. It synthesizes triglycerides (TG) using the fatty acids taken up from plasma or synthesized in situ. These TG are then exported to extrahepatic tissues incorporated along with apoproteins, phospholipids and cholesterol into very low density lipoproteins (VLDL). Finally, the liver is responsible for a large part of the body's cholesterol synthesis.
The in vivo exploration in humans of these multiple and complex metabolic pathways has been mainly limited to the measurements of the amounts of metabolites taken up or produced by the liver, using either tracer methodology or the splanchnic balance technique. Despite some methodologies using the simultaneous infusion of several tracers to obtain insights into hepatic metabolism (Shulman et (Petersen et al, 1966; Rothman et al, 1991; Magnusson et al, 1992 (Magnusson et al, 1992) . NMR can also be used to follow, after administration of a 13 C-labeled tracer, the appearance and distribution of the excess !3C in intrahepatic metabolites (Stromski et al, 1986) as well as in hepatic metabolites sampled using the chemical biopsy techniques (see later) (Dugelay et al, 1994; Hwang et al, 1995; Roden et al, 1996) . This has been used to measure the liver glycogen turnover in human subjects (Magnusson et al, 1994; Roden et al, 1996) and the metabolic pathways used for glycogen repletion after feeding (Hwang et al, 1995; Roden et al, 1996) and ii) some label may be lost through metabolic exchanges during intrahepatic metabolism (this is especially the case when labeled carbons from lactate, pyruvate or alanine cross the oxaloacetate pool on their way to phosphoenolpyruvate) (Hetenyi, 1982 (Zhang et al, 1994) . Moreover, the enrichments are different depending on whether 13 C is introduced as labeled acetate or through the liver metabolism of labeled octanoate or very long chain fatty acids (Zhang et al, 1994 (Landau et al, 1995a) . This method can be adapted to !3C-labeled tracers since the 13 C-labeling pattern of glutamate or of the glutamine part of PAGM can be determined by mass spectrometry Di Donato et al, 1993; Yang et al, 1996) or NMR (Dugelay et al, 1994 (Large et al, 1994 Kelleher and Masterson, 1992; Lee et al, 1992; Peroni et al, 1995) . This ratio permits the calculation of hepatic TP enrichment and therefore, through the comparison of this enrichment to that of glucose, the calculation of the contribution of gluconeogenesis to glucose production (fig 3) . This method takes into account all gluconeogenic pathways and overcomes the problems of dilution of precursor enrichment between the peripheral blood and liver. Evidence has been provided (Neese et al, 1995; Peroni et al, 1995 Peroni et al, , 1996 for the in vitro and in vivo validity of this method for calculating gluconeogenesis when using [2-13 C]glycerol infusion to label hepatic TP. However, other authors (Landau et al, 1995b; Glucose from gluconeogenesis will be labeled but glucose from glycogenolysis will also be labeled since cycling between glucose-6 phosphate and fructose-6 phosphate takes place at a much higher rate than glucose production from glucose-6 phosphate through glucose-6 phosphatase activity. Therefore, the amount of deuterium bound to carbon 6 relative to that bound to carbon 2 provides a measure of the fraction of glucose formed via gluconeogenesis (Landau et al, 1995c (Lee et al, 1994b) . Subsequent studies, however, found higher values (22 and 27 to 30) during in vivo biosynthesis (Lee et al, 1994a; Diraison et al, 1996) . Deuterium enrichment in plasma water is measured by isotope ratio mass spectrometry (IRMS) or by a simpler gas chromatography-mass spectrometry method 
